Epidemiologist Erin Bowles, MPH, is looking at cancer and aging from many different perspectives. Her research brings new insight into breast cancer risk factors, treatment, and survivorship, while helping improve cancer care for patients and families.
Ms. Bowles received an R50 mid-career research award from the National Cancer Institute (NCI). This award is given to cancer researchers who have demonstrated successes and contributions to cancer researcher as a non-principal investigator. As a key member of two large cancer collaborations—the NCI's Breast Cancer Surveillance Consortium and the Health Care Systems Cancer Research Network (CRN)—Ms. Bowles has developed diverse expertise that includes reading mammograms for breast density and using administrative data to understand patterns of care in cancer treatment.
Her current work includes:
Ms. Bowles' experience working with large cancer cohorts has provided her with expertise in data collection and management for other subject areas. She is a co-investigator on the Adult Changes in Thought study team, and oversees their living laboratory and data sharing for aging research, along with an annual research symposium. Finally, she is a member of the Kaiser Permanente Research Affiliates Evidence-based Practice Center and has participated in systematic evidence reviews for the U.S. Preventive Services Task Force.
Breast cancer; colorectal cancer; multiple myeloma; thyroid cancer; pancreatic cancer; biostatistics; epidemiology; mammography; mammographic breast density; cancer treatment; cancer screening and surveillance; automated data collection; quality of care; medication use; care coordination; administrative data
Access to care; health disparities; health outcomes research; quality of life; measurement of change in health care systems; practice variation
Menopause; hormone replacement therapy (HRT); breast cancer
Cognitive health and dementia; biostatistics; epidemiology; medication use; cancer
Pharmacoepidemiology; observational study research methods; chemotherapy; radiation exposure
Jones SM, Ludman EJ, McCorkle R, Reid R, Bowles EJ, Penfold R, Wagner EH. A differential item function analysis of somatic symptoms of depression in people with cancer. J Affect Disord. 2015 Jan 1;170:131-7. doi: 10.1016/j.jad.2014.09.002. Epub 2014 Sep 10. PubMed
Wieneke AE, Bowles EJ, Cronkite D, Wernli KJ, Gao H, Carrell D, Buist DS. Validation of natural language processing to extract breast cancer pathology procedures and results. J Pathol Inform. 2015 Jun 23;6:38. doi: 10.4103/2153-3539.159215. eCollection 2015. PubMed
Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner E. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun;8(2):229-38. doi: 10.1007/s11764-013-0335-1. Epub 2013 Dec 19. PubMed
Ritzwoller DP, Carroll NM, Delate T, Hornbrook MC, Kushi L, Aiello Bowles EJ, Loggers ET, Menter A. Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the Cancer Research Network experience. J Thorac Oncol. 2014 2014 May;9(5):692-701. doi: 10.1097/JTO.0000000000000127. PubMed
Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat. 2014 Apr;144(2):405-16. doi: 10.1007/s10549-014-2870-5. Epub 2014 Feb 21. PubMed
Aiello Bowles EJ, Wernli KJ, Gray HJ, Bogart A, Delate T, O’Keefe-Rosetti M, Nekhylyudov L, Trice Loggers E. Diffusion of intraperitoneal chemotherapy in women with advanced ovarian cancer in community settings 2003-2008: the effect of the NCI clinical recommendation. Front Oncol. 2014 Mar 10;4:43. doi: 10.3389/fonc.2014.00043. eCollection 2014. PubMed
There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones.
A Kaiser Permanente-led BCSC study is among the largest ever to evaluate adding MRI surveillance for breast cancer survivors.
Kaiser Permanente Washington has been part of the national Breast Cancer Surveillance Consortium since 1994. Learn about the Kaiser Permanente Washington Breast Cancer Surveillance Registry here.
HealthDay, Jul 24, 2019